Reimagine Care has announced an expansion of its AI-enabled virtual oncology care program in collaboration with Moffitt Cancer Center, following strong early results that highlight sustained patient engagement, improved symptom management, and reduced reliance on acute care services. The initiative reflects a broader shift in cancer care delivery, moving beyond episodic, clinic-based interactions toward continuous, technology-supported patient monitoring.
The program integrates Reimagine Care’s AI assistant, Remi, with a dedicated oncology virtual care team to provide ongoing support between scheduled appointments. Through conversational interactions, Remi engages patients in real time, enabling structured symptom tracking, facilitating adherence to evidence-based care pathways, and identifying potential clinical concerns earlier. This continuous feedback loop allows care teams to intervene proactively, reducing the likelihood of complications that may otherwise require emergency care.
Data from the initial implementation phase underscores the model’s effectiveness. The program recorded nearly 7,000 patient interactions across proactive check-ins, electronic patient-reported outcomes, symptom management pathways, and clinical escalations. Notably, 97 percent of patient encounters were resolved independently without requiring escalation to Moffitt providers, while only 2.4 percent led to emergency department referrals. In addition, 94 percent of symptom-related issues were managed virtually, allowing patients to remain at home while receiving care.
Patient engagement metrics were also strong, with 99 percent participation in the first month, followed by sustained engagement rates of 81 percent in the second month and 76 percent in the third. Long-term retention reached 63 percent at six months, significantly exceeding typical industry benchmarks, where fewer than 20 percent of patients remain engaged beyond 90 days. Patient satisfaction averaged 9.3 out of 10, with feedback frequently highlighting the responsiveness of the care team and the consistency of Remi’s interactions.
Healthcare leaders involved in the program emphasized the importance of maintaining visibility into patient conditions between visits. By enabling earlier detection of symptom changes and facilitating timely intervention, the model supports more consistent and personalized care throughout the cancer treatment journey. This approach is particularly relevant as oncology services face rising patient volumes, workforce constraints, and increasing treatment complexity.
Unmanaged symptoms remain a major driver of emergency department visits and hospitalizations among cancer patients, many of which can be prevented through timely monitoring and intervention. As a result, hybrid care models that extend clinical oversight beyond traditional settings—without proportionally increasing staffing demands—are gaining traction across healthcare systems.
The next phase of the collaboration will expand the virtual care model to additional patient populations and locations within Moffitt Cancer Center. AI-supported workflows will continue to play a central role, enabling scalable, continuous care delivery while maintaining clinical quality and patient engagement.
Reimagine Care’s leadership noted that traditional oncology care often relies on periodic snapshots from scheduled visits, whereas patients experience symptoms continuously. By combining always-on AI capabilities with clinical expertise, the program aims to provide a more complete and timely understanding of patient needs, ultimately improving outcomes and reducing avoidable escalations.